Business Description
Kamada Ltd. is an Israel-based biopharmaceutical company founded in 1990 that develops and produces therapeutic proteins derived from human plasma, with a focus on treating and preventing serious conditions such as rabies, hepatitis B, hemophilia, and inherited protein deficiencies. The company markets its own portfolio of specialty medicines globally while also acting as a distributor of third-party biopharmaceutical products within Israel, covering a broad range of conditions including respiratory disease, cancer, immunodeficiency, and rare genetic disorders.
